Search
breakthroughsautism
Big Think hosted a panel discussion highlighting cutting-edge autism research as part of our Breakthroughs series, made possible by Pfizer.
This conversation features back-and-forth exchanges between top luminaries in the field, including
Read Less
2mins
Autism science is making great strides, but the search for a cure remains “a marathon, not a sprint.” The challenge is not one disorder but many.
2mins
New drugs for patients may be on the horizon, but “early, intense” behavioral treatment remains “the very best intervention for autism.”
3mins
Four out of five autism sufferers are male. Is something in men’s genes—or brain structure—causing the gap?
3mins
Autism isn’t on the rise: it’s just getting defined better, and diagnosed more.
4mins
Autism sufferers unquestionably have feelings. It’s processing those feelings—and reading them in others—that they struggle with.
6mins
Many kids are vaccinated at age two, the same age at which autism is often first noticed. But the “evidence” that one causes the other doesn’t wash.
4mins
The symptoms of autism are better understood than its causes; psychiatrists classify the disorder as having two major components: impaired social cognition and a tendency toward narrow interests and repetitive […]